International Vaccine Institute
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1997-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.ivi.int
Efficacy, Immunogenicity and Safety of BBIBP-CorV Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
- Conditions
- COVID-19 Disease
- Interventions
- Biological: BBIBP-CorV - Inactivated SARS-CoV-2 vaccine (Vero cell)Biological: influenza season quadrivalent Influenza Vaccine (Flu Quadrivalent)
- First Posted Date
- 2021-07-30
- Last Posted Date
- 2021-08-16
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 8825
- Registration Number
- NCT04984408
Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana
- Conditions
- Typhoid Fever
- Interventions
- Biological: MCV-A vaccineBiological: Vi-TT
- First Posted Date
- 2021-04-21
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 23000
- Registration Number
- NCT04852185
- Locations
- 🇬🇭
Kwame Nkrumah University of Science and Technology, Kumasi, Ashanti, Ghana
Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™
- Conditions
- Cholera
- Interventions
- Biological: Oral Cholera Vaccine Simplified (OCV-S)Biological: Shanchol™
- First Posted Date
- 2021-02-18
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 2530
- Registration Number
- NCT04760236
- Locations
- 🇳🇵
Nepalgunj medical college, Banke, City- Nepalgunj, Nepal
🇳🇵B.P.Koirala Institute of Health Sciences, Rautahat, Dharan, Nepal
🇳🇵Dhulikhel Hospital, Kavre, Dhulikhel, Nepal
Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia
- Conditions
- Chikungunya
- Interventions
- Drug: BBV87 Chikungunya vaccineDrug: Normal Saline
- First Posted Date
- 2020-09-28
- Last Posted Date
- 2023-04-19
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 3210
- Registration Number
- NCT04566484
- Locations
- 🇨🇴
Clínica de la Costa, Barranquilla, Atlantico, Colombia
🇬🇹Centro de Estudios Clínicos Salud Avanzada. (CECLISA), Guatemala city, Guatemala
🇨🇴Centro de Atención en Investigación Médica (CAIMED)., Yopal, Casanare, Colombia
Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19
- Conditions
- Coronavirus InfectionSARS-CoV 2
- Interventions
- Biological: INO-4800Device: CELLECTRA® 2000Other: Saline-sodium citrate (SSC) buffer
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2022-07-18
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 79
- Registration Number
- NCT04447781
- Locations
- 🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
🇰🇷Seoul National University Hospital, Seoul, Korea, Republic of
Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III)
- Conditions
- Typhoid
- Interventions
- Biological: Vi-DT (Multi-dose formulation)Biological: Vi-DT (Single dose formulation)Biological: Control Vaccine
- First Posted Date
- 2019-12-18
- Last Posted Date
- 2021-08-27
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 1800
- Registration Number
- NCT04204096
- Locations
- 🇵🇭
Putatan Research Center, Muntinlupa, Metro Manila, Philippines
🇵🇭Lingga Health Research Center, Calamba, Laguna, Philippines
🇵🇭University of the Philippines Manila-National Institutes of Health, Manila, Philippines
Immune Non-inferiority and Safety of a Vi-DT Typhoid Conjugate Vaccine
- Conditions
- Typhoid
- Interventions
- Biological: Test Vaccine Vi-DT Typhoid conjugateBiological: Control Vaccine Typbar TCV®
- First Posted Date
- 2019-05-01
- Last Posted Date
- 2020-04-22
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 1800
- Registration Number
- NCT03933098
- Locations
- 🇳🇵
Nepalgunj medical college, Banke, City- Nepalgunj, Nepal
🇳🇵Dhulikhel Hospital, Kavre, Dhulikhel, Nepal
🇳🇵Kanti Children's Hospital, Kathmandu, Sukedhara, Nepal
Effectiveness of Single Dose or Two Doses of Bivalent HPV Vaccine in Thailand
- Conditions
- Healthy
- Interventions
- Biological: Bivalent HPV vaccine CERVARIX®
- First Posted Date
- 2018-11-20
- Last Posted Date
- 2020-04-22
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 18000
- Registration Number
- NCT03747770
- Locations
- 🇹🇭
Ministry of Public Health, Bangkok, Chang Wat Nonthaburi, Thailand
Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine
- Conditions
- Typhoid
- Interventions
- Biological: Vi-DTBiological: FluQuadri™Other: 0.9% sodium chloride isotonic solution
- First Posted Date
- 2018-05-17
- Last Posted Date
- 2021-08-27
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 285
- Registration Number
- NCT03527355
- Locations
- 🇵🇭
Research Institute for Tropical Medicine(RITM), Alabang, Muntinlupa City, Philippines
Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine
- Conditions
- Typhoid
- Interventions
- Biological: Vi-DTBiological: Typhim Vi®Biological: VAXIGRIP®
- First Posted Date
- 2016-01-01
- Last Posted Date
- 2020-04-28
- Lead Sponsor
- International Vaccine Institute
- Target Recruit Count
- 144
- Registration Number
- NCT02645032